Reprogramming Myeloid Cells for Cancer: CAR-M from Ex Vivo to In Vivo
Time: 3:15 pm
day: Conference Day One
Details:
- Targeting macrophages with CARs for solid tumors
- Investigating pre-clinical and clinical data with ex vivo CAR-M cell therapies
- Describing our in vivo CAR-M platform that is being developed in partnership with Moderna
